MedTrace Logo

Vietnam Cryptococcal Retention in Care Study - Version 2.1

NCT03267407 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1184

Last updated 2017-09-12

No results posted yet for this study

Summary

This is a multicenter prospective cohort evaluation of the implementation of a cryptococcal antigen (CrAg) screening program at selected outpatient HIV clinics (OPCs) and network laboratories in Vietnam.

Conditions

  • HIV/AIDS
  • Cryptococcal Meningitis
  • Opportunistic Infections, HIV Related
  • Cryptococcosis
  • Mycosis; Opportunistic
  • Mycosis Fungoides

Interventions

OTHER

Preemptive high-dose Fluconazole

Patients with advanced HIV diseases are screened for Cryptococcal Antigen using LFA CrAg tests. Then patients with CrAg positivity and without meningitis are given preemptive high-dose fluconazole to prevent the development of cryptococcal meningitis, which is one of the leading cause of death among immunocompromized patients.

Sponsors & Collaborators

Principal Investigators

  • Kinh V Nguyen, MD · National Hospital for Tropical Diseases, Hanoi, Vietnam

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-14
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • Vietnam

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03267407 on ClinicalTrials.gov